The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

Goods shipped from the country face a 39 percent tariff in the U.S., which companies warn will have dire consequences if ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

Swiss leaders refrained from implementing countermeasures against sweeping US tariffs and instead want to focus on further ...

President Trump sees Switzerland as doing too little to address its trade deficit with the U.S., a gap he focused on as he ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

Switzerland removed tariffs on nearly all imports in 2024, and had virtually free access to its markets for U.S. products.

The tariff talks in Washington are being led by Helene Budliger Artieda, head of the State Secretariat for Economic Affairs ...

The disastrous outcome brought home Switzerland’s lack of leverage in an era of global instability and the misguidedness of ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

America’s goods trade deficit with Switzerland reached $38 billion last year and nearly $48 billion in the first half of 2025, driven mainly by a surge in gold imports. Gold refining is a dominant ...